Equities analysts expect Aetna Inc (NYSE:AET) to post earnings of $1.18 per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Aetna’s earnings, with the highest EPS estimate coming in at $1.29 and the lowest estimate coming in at $1.12. Aetna posted earnings per share of $1.63 in the same quarter last year, which would indicate a negative year over year growth rate of 27.6%. The firm is scheduled to announce its next quarterly earnings report on Tuesday, January 30th.

On average, analysts expect that Aetna will report full-year earnings of $9.78 per share for the current financial year, with EPS estimates ranging from $9.73 to $9.93. For the next fiscal year, analysts anticipate that the firm will post earnings of $10.09 per share, with EPS estimates ranging from $9.84 to $10.35. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that follow Aetna.

Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping the Zacks’ consensus estimate of $2.06 by $0.39. The firm had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business’s revenue for the quarter was down 5.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.07 earnings per share.

AET has been the topic of several recent research reports. Piper Jaffray Companies reiterated a “hold” rating and set a $187.00 target price on shares of Aetna in a report on Friday, November 3rd. Zacks Investment Research cut shares of Aetna from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Argus cut shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price on the stock. in a report on Wednesday, December 6th. BMO Capital Markets increased their target price on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a report on Friday, October 27th. Finally, Cantor Fitzgerald cut shares of Aetna from an “overweight” rating to a “neutral” rating in a report on Thursday, October 26th. Twelve analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Aetna presently has a consensus rating of “Buy” and an average price target of $175.19.

In related news, President Karen S. Lynch sold 15,271 shares of the stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Several institutional investors have recently made changes to their positions in AET. AXA raised its position in Aetna by 16.6% during the 3rd quarter. AXA now owns 274,863 shares of the company’s stock worth $43,706,000 after buying an additional 39,125 shares during the last quarter. Wagner Bowman Management Corp raised its position in Aetna by 44.4% during the 3rd quarter. Wagner Bowman Management Corp now owns 1,954 shares of the company’s stock worth $310,000 after buying an additional 601 shares during the last quarter. Shelton Capital Management raised its position in Aetna by 326.3% during the 3rd quarter. Shelton Capital Management now owns 20,568 shares of the company’s stock worth $3,271,000 after buying an additional 15,743 shares during the last quarter. Steward Partners Investment Advisory LLC purchased a new position in Aetna during the 3rd quarter worth approximately $324,000. Finally, Public Employees Retirement System of Ohio raised its position in Aetna by 6.2% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 245,524 shares of the company’s stock worth $39,041,000 after buying an additional 14,324 shares during the last quarter. 88.01% of the stock is owned by hedge funds and other institutional investors.

Shares of Aetna (NYSE:AET) traded down $0.24 during trading on Wednesday, reaching $181.33. 3,211,700 shares of the company’s stock traded hands, compared to its average volume of 2,602,621. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna has a one year low of $116.04 and a one year high of $192.37. The company has a market cap of $59,223.11, a PE ratio of 17.78, a price-to-earnings-growth ratio of 1.65 and a beta of 0.61.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Wednesday, January 10th. Aetna’s dividend payout ratio is currently 37.04%.

COPYRIGHT VIOLATION WARNING: “Aetna Inc (AET) Expected to Post Earnings of $1.18 Per Share” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of US & international copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/13/aetna-inc-aet-expected-to-post-earnings-of-1-18-per-share.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Get a free copy of the Zacks research report on Aetna (AET)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related stocks with our FREE daily email newsletter.